Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Attention and memory dysfunctions in mild multiple sclerosis.

Michael Tinnefeld1, Friederike H Treitz, Claus G Haase

  • 1Institute of Cognitive Neuroscience, Department of Clinical Neuropsychology, Ruhr-University of Bochum, Universitaetsstrasse 150, 44780, Bochum, Germany.

European Archives of Psychiatry and Clinical Neuroscience
|January 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of antipsychotic drugs on microglia-mediated neuroinflammation in schizophrenia: perspectives in an astrocyte-microglia co-culture model.

Frontiers in psychiatry·2025
Same author

Neuroglia in autoimmune encephalitis.

Handbook of clinical neurology·2025
Same author

Microglia as potential key regulators in viral-induced neuroinflammation.

Frontiers in cellular neuroscience·2024
Same author

Tiagabine and zonisamide differentially regulate the glial properties in an astrocyte-microglia co-culture model of inflammation.

Naunyn-Schmiedeberg's archives of pharmacology·2023
Same author

The potential role of astroglial GABA<sub>A</sub> receptors in autoimmune encephalitis associated with GABA<sub>A</sub> receptor antibodies and seizures.

Epilepsia open·2023
Same author

Inhibition of Microglial Activation by Amitriptyline and Doxepin in Interferon-β Pre-Treated Astrocyte-Microglia Co-Culture Model of Inflammation.

Brain sciences·2023
Same journal

Abnormal emotional intensity processing in individuals at clinical high risk for psychosis: evidence from event-related potentials.

European archives of psychiatry and clinical neuroscience·2026
Same journal

The role of attention in perceptual biases in patients with schizophrenia spectrum disorder and healthy controls.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Effects of quetiapine on cognitive functioning in schizophrenia: evidence for the remyelination hypothesis?

European archives of psychiatry and clinical neuroscience·2026
Same journal

Effects of xanomeline-trospium on the gut-lung microbiota axis and susceptibility to LPS-induced acute lung injury in male and female mice.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Association of the red blood cell distribution width-to-albumin ratio with incident depression and depressive symptom trajectories in older adults.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Major depressive disorder-alcohol use disorder comorbidity: diagnosis, mechanisms and treatment.

European archives of psychiatry and clinical neuroscience·2026
See all related articles

Cognitive dysfunction and visual processing deficits occur in multiple sclerosis (MS) even before significant physical disability is apparent. Early detection of these impairments is crucial for managing the central nervous system affection.

Area of Science:

  • Neuroscience
  • Clinical Neurology

Background:

  • Multiple sclerosis (MS) is a chronic demyelinating disease affecting the central nervous system (CNS).
  • Cognitive dysfunction is a common but often overlooked symptom in MS, even in early stages.
  • Visual evoked potentials (VEPs) can assess early visual pathway integrity.

Purpose of the Study:

  • To investigate the relationship between clinical disability and cognitive dysfunction in MS patients.
  • To evaluate early visual processing using VEPs in MS patients with varying disability levels.
  • To determine if cognitive deficits are present in MS patients without physical disability.

Main Methods:

  • Studied disability-free (EDSS <= 1.5) and mildly to moderately disabled (EDSS 2-6) MS patients, alongside healthy controls.
  • Assessed attention, verbal memory, nonverbal memory, and early visual processing via VEPs.

Related Experiment Videos

  • Compared cognitive performance and VEP results across the three groups.

    • Main Results:

    • Disability-free MS patients exhibited mild impairments in alertness and divided attention.
    • Mildly to moderately disabled patients showed more pronounced cognitive deficits, including nonverbal memory impairment.
    • Half of all MS patients had abnormal VEP latencies despite normal visual acuity.

    Conclusions:

    • Cognitive deficits are present in multiple sclerosis (MS) from its early stages, even without apparent physical disability.
    • Perceptual impairments, indicated by abnormal VEPs, should be considered part of the CNS affection in MS, irrespective of visual acuity.
    • Early assessment of cognitive function and visual processing is vital for comprehensive MS management.